Vimarsana
Biggest News Aggregation in the World

Khalid El Sayed News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Khalid El Sayed. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Khalid El Sayed Today - Breaking & Trending Today

ULM partnership takes olive oil extract from research to market - Vimarsana News

ULM partnership takes olive oil extract from research to market

The product extracts a key ingredient from olive oil

Source: kedm.org
ULM's product enters the healthy aging market - Vimarsana News

ULM's product enters the healthy aging market

Oleolive has done extensive testing before going to the market in order to gain the trust of consumers in that our product is of the highest grade possible with documented benefits.

Source: kedm.org
ULM's product enters the healthy aging market - Vimarsana News

ULM's product enters the healthy aging market

Almost five years ago, ULM entered into a licensing arrangement with Oleolive Inc, a private biotechnology company, to develop the marketing and commercialization of Dr. Khalid El Sayed’s research on the health benefits of olive oil. Dr. El Sayed’s research isolated oleocanthal, a phenolic compound found in trace amounts in olive oil and demonstrated oleocanthal’s contribution to the health beneficial properties of extra virgin olive oil (EVOO). The result is a product that has been branded Oligen.

Source: ulm.edu
ULM's Khalid El Sayed awarded funding to research prostate cancer - Vimarsana News

ULM's Khalid El Sayed awarded funding to research prostate cancer

The research will focus on treating a recurrence of prostate cancer, for which there is just a 29% survival rate

ULM's El Sayed awarded funding to research new treatment for prostate cancer recurrence - Vimarsana News

ULM's El Sayed awarded funding to research new treatment for prostate cancer recurrence

The University of Louisiana Monroe's El Sayed has been awarded funding towards research for a treatment for prostate cancer recurrence.

Source: kedm.org